National Partnership to Improve Dementia Care in Nursing Homes: Antipsychotic Medication Use Data Report (March 2017)
The Centers for Medicare & Medicaid Services (CMS) is tracking the progress of the National Partnership to Improve Dementia Care in Nursing Homes by reviewing publicly reported measures. The official measure of the Partnership is the percentage of long-stay nursing home residents who are receiving an antipsychotic medication, excluding those residents diagnosed with schizophrenia, Huntington's Disease, or Tourette’s Syndrome. In the fourth quarter of 2011, 23.9 percent of long-stay nursing home residents were receiving an antipsychotic medication; since then there has been a decrease of 33.2 percent to a national prevalence of 16 percent in the fourth quarter of 2016. Success has varied by state and CMS region, with many states and regions having seen a reduction of greater than 30 percent.
A four-quarter average of this measure is posted to the Nursing Home Compare website.
For more information on the National Partnership, please send correspondence to email@example.com.
To see a breakdown of use by states and Regions click here.